Benefit of Apabetalone on Plasma Proteins in Renal Disease
Sign Up to like & getrecommendations! Published in 2018 at "Kidney International Reports"
DOI: 10.1016/j.ekir.2017.12.001
Abstract: Introduction Apabetalone, a small molecule inhibitor, targets epigenetic readers termed BET proteins that contribute to gene dysregulation in human disorders. Apabetalone has in vitro and in vivo anti-inflammatory and antiatherosclerotic properties. In phase 2 clinical… read more here.
Keywords: apabetalone plasma; renal disease; disease; plasma proteins ... See more keywords